Imagine a career in a field you can’t imagine. Dominique Constantini parlayed her commitment to immunology to meeting unmet ...

JNJ's regulatory filing seeks the FDA's approval for TAR-200, a drug-device combination for treating certain bladder cancer ...

J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...

An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...

Through the Kenya Medical Supplies Authority (KEMSA) Chief Executive Officer Waqo Erjesa, the government confirmed that there ...

This lies against a backdrop of a nationwide shortage of BCG vaccines, as reports indicated that it has been out of stock for ...

A nationwide shortage of BCG vaccines in the country leaves Kenyan newborns vulnerable to TB, a disease with a high ...

The country has run out of essential medical supplies, precipitating a serious national public healthcare crisis. The lack of HIV medication, condoms and baby vaccines is endangering millions of lives ...

An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin (BCG) immunotherapy, a vaccine also used ...

Kenya has completely run out of essential medical supplies—including HIV medicines, testing kits, and vaccines—putting ...

Counties are facing limited supplies or no stock at all, leaving newborns vulnerable to TB. Health advocates are urging the ...